Tag: Prescription Drugs
Single-Dose Baloxavir Treatment Can Reduce Influenza Transmission
Transmission of laboratory-confirmed influenza significantly lower with baloxavir versus placebo by day 5
Most Patients Newly Diagnosed With A-Fib Do Not Receive Anticoagulants
One-year stroke risk was 0.7 and 1.8 percent for patients with CHA2DS2-VA scores of 1 to 4 and 5 to 8
FDA Approves Dupixent for Chronic Spontaneous Urticaria
Approval granted for adults and children 12 years and older who remain symptomatic despite antihistamine treatment
Many ADHD Medications Lead to Increases in Blood Pressure and Heart Rate
Increases in hemodynamic signs seen with amphetamines, atomoxetine, lisdexamfetamine, methylphenidate, and viloxazine
Midafternoon Dosing Improves Lung Function in Atopic Asthma
Improvement seen in nocturnal lung function and overnight suppression of blood eosinophil counts
Flares Occur Frequently in Generalized Pustular Psoriasis
Frequent treatment alterations of off-label biologics and nonsteroidal systemic agents observed
FDA Approves Self-Injection of Vyvgart Hytrulo
Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy
FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer
The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenib
Breast Surgery Can Be Omitted After Neoadjuvant Systemic Therapy in Select Patients
Patients with initial nodal metastases and breast pCR on vacuum-assisted biopsy who underwent targeted axillary dissection had axillary pCR
AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
Tolebrutinib treatment associated with 31 percent risk reduction in six-month confirmed disability progression versus placebo
